Evaluation of Use of Brain Activity Monitoring for Prediction of Migraine Attacks

Brainmarc

Status

Unknown

Conditions

Migraine

Treatments

Device: EEG monitoring (MindWave by NeuroSky)

Device: EEG monitoring (EPOC by Emotiv)

Study type

Interventional

Funder types

Industry

Identifiers

NCT02583581

CLD4

Details and patient eligibility

About

This study evaluates the use of brain activity monitoring for prediction of migraine attacks in an expected time scale of 12-48 hours prior to the migraine attack.

Full description

The study will be conducted in one are. Participants diagnosed with migraine, will be evaluated for their EEG characteristics as well as daily migraine related clinical and general status. Participants' monitoring will be conducted for 20 times for a duration of one month.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Diagnosed with migraine by a neurologist.
Male or Female, aged 18 -50 years.
Able and willing to comply with all study requirements.
Having 3-10 migraine attacks per month.

Exclusion criteria

Diagnosed with chronic pain, neurological or psychiatric disorders.
Current or past use of anti-depressants.
A user of recreational or illicit drugs or has had a recent history of drug or alcohol abuse or dependence.
History of seizures
Head injury with consciousness loss in the last three months.
Diagnosed as ADHD and/or use of Ritalin.
Hearing disorder and/or known ear drum impairment.
Having migraine attacks occurring only during the menstruation.